These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32415493)

  • 1. Data science-driven analyses of drugs inducing hypertension as an adverse effect.
    Sharma R
    Mol Divers; 2021 May; 25(2):801-810. PubMed ID: 32415493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions.
    Yu H; Nysak S; Garg N; Ong E; Ye X; Zhang X; He Y
    BMC Bioinformatics; 2019 May; 20(Suppl 7):199. PubMed ID: 31074377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based approach highlighting interplay among anti-hypertensives: target coding-genes: diseases.
    Sharma R
    Sci Rep; 2020 Nov; 10(1):20152. PubMed ID: 33214616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence.
    Matthews EJ; Frid AA
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):247-75. PubMed ID: 19932726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities.
    Matthews EJ; Kruhlak NL; Benz RD; Aragonés Sabaté D; Marchant CA; Contrera JF
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):43-65. PubMed ID: 19422100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.
    Wang L; Li M; Xie J; Cao Y; Liu H; He Y
    Sci Rep; 2017 Oct; 7(1):13819. PubMed ID: 29061976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the incorporation of structural alerts be restricted in drug design? An analysis of structure-toxicity trends with aniline-based drugs.
    Kalgutkar AS
    Curr Med Chem; 2015; 22(4):438-64. PubMed ID: 25388012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing drug safety of hepatitis C therapies using post-market data.
    Huang J; Zhang X; Tong J; Du J; Duan R; Yang L; Moore JH; Tao C; Chen Y
    BMC Med Inform Decis Mak; 2019 Aug; 19(Suppl 4):147. PubMed ID: 31391106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Drug Reactions for Medicines Newly Approved in Japan from 1999 to 2013: Hypertension and Hypotension.
    Nagayama T; Nishida M; Hizue M; Ogino Y; Fujiyoshi M
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):306-12. PubMed ID: 26407539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of drugs with different risk profiles.
    Saedder EA; Brock B; Nielsen LP; Bonnerup DK; Lisby M
    Dan Med J; 2015 Aug; 62(8):A5118. PubMed ID: 26239589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Side-Effect Profiles Prediction: From Empirical to Structural Risk Minimization.
    Jiang H; Qiu Y; Hou W; Cheng X; Yim MY; Ching WK
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(2):402-410. PubMed ID: 29994681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hypertension due to drugs and toxins.
    Gyamlani G; Geraci SA
    South Med J; 2007 Jul; 100(7):692-9; quiz 700, 708. PubMed ID: 17639749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.
    Mahr A; Golmard C; Pham E; Iordache L; Deville L; Faure P
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):731-741. PubMed ID: 28176407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern.
    Munro IC; Ford RA; Kennepohl E; Sprenger JG
    Food Chem Toxicol; 1996 Sep; 34(9):829-67. PubMed ID: 8972878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities.
    Ursem CJ; Kruhlak NL; Contrera JF; MacLaughlin PM; Benz RD; Matthews EJ
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):1-22. PubMed ID: 19422096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drugs: an underestimated cause of arterial hypertension].
    Serveaux M; Burnier M; Pruijm M
    Rev Med Suisse; 2014 Sep; 10(441):1661-2, 1664-5. PubMed ID: 25322625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of adverse drug reactions using decision tree modeling.
    Hammann F; Gutmann H; Vogt N; Helma C; Drewe J
    Clin Pharmacol Ther; 2010 Jul; 88(1):52-9. PubMed ID: 20220749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities.
    Matthews EJ; Ursem CJ; Kruhlak NL; Benz RD; Sabaté DA; Yang C; Klopman G; Contrera JF
    Regul Toxicol Pharmacol; 2009 Jun; 54(1):23-42. PubMed ID: 19422098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of FDA class C drugs approved from 1981 to 1988.
    Yasuda SU; Woosley RL
    Clin Pharmacol Ther; 1992 Dec; 52(6):577-82. PubMed ID: 1458766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.